Completed Access to Information Requests

About this information

Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).

If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.

*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.

Download datasets of the summaries of completed access to information requests.

Current Search

Report Type

Organization

Disposition

Year

Month

Found 176 record(s)

Req # A-2021-001848

A month by month breakdown of requisitions for COVID Rapid Antigen Tests, by type, ordered by The Province of British Columbia, starting in 2020 to 2022-02-24.

Organization: Health Canada

3 page(s)
February 2022

Req # A-2019-002054

Adverse Drug Reaction (ADR). Report number: E2B_02803860.

Organization: Health Canada

13 page(s)
February 2022

Req # A-2019-002063

Adverse Drug Reaction (ADR) for IXAZOMIB. Report number: E2B_02897412.

Organization: Health Canada

19 page(s)
February 2022

Req # A-2020-000057

Adverse Drug Reaction (ADR). Report number: 02517334.

Organization: Health Canada

18 page(s)
February 2022

Req # A-2020-000078

Adverse Drug Reaction (ADR) for VANDETANIB. Report number: E2B_02536410.

Organization: Health Canada

7 page(s)
February 2022

Req # A-2021-000354

Adverse Drug Reaction (ADR) for AMLODIPINE BESILATE. Report number: E2B_03566994.

Organization: Health Canada

28 page(s)
February 2022

Req # A-2021-001066

Adverse Drug Reaction (ADR) for INSULIN GLARGINE. Report number: E2B_03861558.

Organization: Health Canada

33 page(s)
February 2022

Req # A-2021-001191

Briefing note in the Ministerial Executive Correspondence System (MECS) for the following file: 21-111766-914, COVID-19 Mass Vaccination Advertising Campaign.

Organization: Health Canada

3 page(s)
February 2022

Req # A-2021-001228

Adverse Drug Reaction (ADR) for LEVOMEPROMAZINE. Report number: E2B_03452251.

Organization: Health Canada

22 page(s)
February 2022

Req # A-2021-001345

Adverse Drug Reaction (ADR) for FUROSEMIDE. Report number: E2B 03482529.

Organization: Health Canada

16 page(s)
February 2022
Date modified: